Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04400526
Other study ID # BDF 190003
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date September 30, 2023

Study information

Verified date May 2020
Source The Hong Kong Polytechnic University
Contact Ka Yan Ho, PhD
Phone 27666417
Email kyeva.ho@polyu.edu.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hidden drug abuse remains a significant concern for public health. An appropriate intervention is necessary to encourage hidden drug abusers to report their situations and seek professional help. This project aims to develop a community-based network to identify and refer hidden drug abusers in Hong Kong, and assess its effectiveness.


Description:

This study will be completed within 18 months, and be divided into 3 Phases, including (1) a video competition for anti-drug abuse, (2) development of a community-based network through training 150 peers aged 13-18 as anti-drug ambassadors (ADAs) to deliver anti-drug messages based on the AWARD model, and (3) a mass promotional campaign organized by ADAs in the community. A one-group pre-test and repeated post-test design will be adopted to evaluate the overall effectiveness of the community-based network. We will assess the knowledge, attitudes and practices regarding anti-drug abuse of the ADAs. Data collection will be conducted at baseline, post-training, 3 months and 6 months after the training workshop.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 250
Est. completion date September 30, 2023
Est. primary completion date July 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years to 18 Years
Eligibility Inclusion Criteria: - Aged 13 - 18 years - Able to speak Cantonese and read Chinese Exclusion Criteria: - identified cognitive, behavioral or learning problem(s) - identified mental illness(es)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
A video competition
Each Individual/group will be required to produce a maximum of 2-minute video on one of the following themes: (1) the hazardous effects of drug especially less psychotropic drugs such as Cannabis, (2) encouraging messages to drug abusers, and (3) existing anti-drug services.
A training workshop
The workshop will last for 6 hours, and will be delivered by an experienced counsellor from C.H.O.I.C.E. The content of the workshop will include (1) hazardous effects of drug abuse especially less psychotropic drugs such as Cannabis, (2) signs and symptoms of drug abuse particularly less psychotropic drugs like Cannabis, (3) alternatives to drug abuse, (4) community resources available, and (5) how to refer drug abusers. Besides, all children will be taught to use the AWARD model for referrals in the workshop.
A mass promotional campaign
Children who complete the training workshop in phase 2 will be invited to join phase 3. They are encouraged to design their own promotional activities for community members in the targeted districts. The activities can be delivered by a group (a maximum of 5 ADAs per group) or by an individual. Types of activities can include but not limited to health talks, booths, outreaching activities, games, posters, leaflets and websites. Likewise, if the ADAs encounter any drug abuser in their social circles, the ADAs will be asked to deliver a brief advice based on the AWARD model.

Locations

Country Name City State
Hong Kong Ka Yan HO Hong Kong Hong Kong, China

Sponsors (1)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in knowledge about the hazardous effects of drug abuse among ADAs by using Beat Drugs Fund Evaluation Question Set No. 2 Change in knowledge about the hazardous effects of drug abuse among ADAs immediately after the training workshop when compared to baseline Immediately after the training workshop
Secondary Change in knowledge about the hazardous effects of drug abuse among ADAs by using Beat Drugs Fund Evaluation Question Set No. 2 Change in knowledge about the hazardous effects of drug abuse among ADAs at 3 months after the training workshop when compared to baseline 3 months after the training workshop
Secondary Change in knowledge about the hazardous effects of drug abuse among ADAs by using Beat Drugs Fund Evaluation Question Set No. 2 Change in knowledge about the hazardous effects of drug abuse among ADAs at 6 months after the training workshop when compared to baseline 6 months after the training workshop
Secondary Change in attitudes towards drug abuse and anti-drug abuse among ADAs by using Beat Drugs Fund Evaluation Question Set No. 1 Change in attitudes towards drug abuse and anti-drug abuse among ADAs immediately after the training workshop when compared to baseline Immediately after the training workshop
Secondary Change in attitudes towards drug abuse and anti-drug abuse among ADAs by using Beat Drugs Fund Evaluation Question Set No. 1 Change in attitudes towards drug abuse and anti-drug abuse among ADAs at 3 months after the training workshop when compared to baseline 3 months after the training workshop
Secondary Change in attitudes towards drug abuse and anti-drug abuse among ADAs by using Beat Drugs Fund Evaluation Question Set No. 1 Change in attitudes towards drug abuse and anti-drug abuse among ADAs at 6 months after the training workshop when compared to baseline 6 months after the training workshop
Secondary Change in anti-drug practices among ADAs by using Anti-Drug Practice Questionnaires Personal development questions among ADAs at 3 months after the training workshop when compared to baseline 3 months after the training workshop
Secondary Change in anti-drug practices among ADAs by using Anti-Drug Practice Questionnaires Personal development questions among ADAs at 6 months after the training workshop when compared to baseline 6 months after the training workshop
See also
  Status Clinical Trial Phase
Recruiting NCT06320626 - Pharmacokinetic-guided Dosing of Emicizumab Phase 4
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Active, not recruiting NCT04559633 - Cognitive and Behavioral Therapy in School Refusal N/A
Recruiting NCT05706376 - An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention N/A
Completed NCT04409106 - The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
Enrolling by invitation NCT03312504 - Implementing a School Prevention Program to Reduce Injuries Through Neuromuscular Training N/A
Completed NCT04103632 - Screening and Diagnosing Exercise-induced Bronchoconstriction in Recreational Young Athletes (12-18 y) N/A
Completed NCT04448678 - Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients N/A
Completed NCT01718080 - The Effects of Puberty and Weight on Sugar Metabolism in Children N/A
Recruiting NCT05423444 - Neural Connectivity During Therapy for Adolescent PTSD N/A
Completed NCT04443231 - Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
Not yet recruiting NCT03874078 - Turkish Version of Kids BESTest, Validity and Reliability for School-Aged Children
Recruiting NCT05265689 - Study to Improve Adolescent Bicycling Safety N/A
Enrolling by invitation NCT05572398 - Online Bullying Bystander Intervention for Middle Schools Phase II N/A
Recruiting NCT03176875 - Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease N/A
Completed NCT03842735 - Physical Activity in Children During Hematopoietic Stem Cells Transplantation (HSCT) N/A
Completed NCT00956527 - Martial Arts as Early Intervention for Teen Drug Abuse N/A
Recruiting NCT06211517 - Drugs Experience for Adolescents With Anorexia
Active, not recruiting NCT04893447 - Suicide Prevention Among Recipients of Care N/A
Recruiting NCT05799053 - Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study Phase 3